Biodexa Pharmaceuticals Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada.
Pharmaceuticals Company Announces Confirmation Study Approval For Type 1 Diabetes Treatment
Pharmaceuticals Company Announces…
Pharmaceuticals Company Announces Confirmation Study Approval For Type 1 Diabetes Treatment
Biodexa Pharmaceuticals Announces Phase 2a Study of Tolimidone in Type 1 Diabetes Approved by Health Canada.